Abstract:Chronic organ injury leads to fibrosis and eventually organ failure. Fibrosis is characterized by excessive synthesis, remodeling, and contraction of extracellular matrix produced by myofibroblasts. Myofibroblasts are the key cells in the pathophysiology of fibrotic disorders and their differentiation can be triggered by multiple stimuli. To develop anti-fibrotic therapies, it is of paramount importance to understand the molecular basis of the signaling pathways contributing to the activation and maintenance of myofibroblasts. Several signal transduction pathways, such as transforming growth factor (TGF)-β, Wingless/Int (WNT), and more recently yes-associated protein 1 (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) signaling, have been linked to the pathophysiology of fibrosis. Activation of the TGF-β1-induced SMAD complex results in the upregulation of genes important for myofibroblast function. Similarly, WNT-stabilized β-catenin translocates to the nucleus and initiates transcription of its target genes. YAP and TAZ are two transcriptional co-activators from the Hippo signaling pathway that also rely on nuclear translocation for their functioning. These three signal transduction pathways have little molecular similarity but do share one principle: the cytosolic/nuclear regulation of its transcriptional activators. Past research on these pathways often focused on the isolated cascades without taking other signaling pathways into account. Recent developments show that parts of these pathways converge into an intricate network that governs the activation and maintenance of the myofibroblast phenotype. In this review, we discuss the current understanding on the signal integration between the TGF-β, WNT, and YAP/TAZ pathways in the development of organ fibrosis. Taking a network-wide view on signal transduction will provide a better understanding on the complex and versatile processes that underlie the pathophysiology of fibrotic disorders.

YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways

YAP/TAZ Signaling in the Pathobiology of Pulmonary Fibrosis

Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.

Hippo signaling pathway in lung development, regeneration, and diseases.

YAP/TAZ: Molecular pathway and disease therapy

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

YAP Alleviates Pulmonary Fibrosis Through Promoting Alveolar Regeneration via Modulating the Stemness of Alveolar Type 2 Cells

Critical role of PAFR/YAP1 positive feedback loop in cardiac fibrosis

YAP/TAZ for Cancer Therapy: Opportunities and Challenges (Review).

YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis

Fibroblast Yap/Taz Signaling in Extracellular Matrix Homeostasis and Tissue Fibrosis

An overview of signaling pathways regulating YAP/TAZ activity

TEAD Mediates YAP-dependent Gene Induction and Growth Control

Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury

YAP/TAZ as mechanobiological signaling pathway in cardiovascular physiological regulation and pathogenesis

Therapeutic Targeting of Src Kinase and Myofibroblast Activation in Pulmonary Fibrosis

Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge

A review on decoding the roles of YAP/TAZ signaling pathway in cardiovascular diseases: Bridging molecular mechanisms to therapeutic insights

Airway secretory cell fate conversion via YAP-mTORC1-dependent essential amino acid metabolism

Role of YAP/TAZ in Cell Lineage Fate Determination and Related Signaling Pathways